Purple Biotech (PPBT) Operating Income (2014 - 2026)
Purple Biotech (PPBT) reported Operating Income of $2.3 million for Q1 2026, up 60.1% year-over-year from $1.4 million in Q1 2025, and down 90.4% quarter-over-quarter from $23.4 million in Q4 2025.
Purple Biotech (PPBT) Operating Income (2014 - 2026) Analysis & Trends
Purple Biotech (PPBT) has 13 years of Operating Income data on file, last reported at $2.3 million in Q1 2026.
- Operating Income for Q1 2026 came in at $2.3 million, up 60.1% year-over-year; the trailing twelve-month figure through Mar 2026 was $28.3 million (up 253.18% YoY), and the FY2025 annual result was $27.5 million, up 149.5% from the prior year.
- Operating Income fell to $2.3 million in Q1 2026 per PPBT's latest filing, from $23.4 million in the prior quarter.
- Over five years, Operating Income peaked at $23.4 million in Q4 2025 and troughed at $1.0 million in Q4 2024.
- A 5-year average of $5.0 million and a median of $4.5 million in 2024 frame the typical range for Operating Income.
- The sharpest annual moves came in 2024 and 2025: Operating Income tumbled 83.79% in 2024, then jumped 2207.68% in 2025.
- A 5-year view of Operating Income shows it stood at $6.6 million in 2022, then declined by 5.06% to $6.3 million in 2023, then plunged by 83.79% to $1.0 million in 2024, then jumped by 2207.68% to $23.4 million in 2025, then sank by 90.4% to $2.3 million in 2026.
- Business Quant data shows PPBT's Operating Income at $2.3 million in Q1 2026, $23.4 million in Q4 2025, and $1.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -32.68 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -19.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.82 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -15.76 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.14 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -65.83 Mn |
| 10 | Purple Biotech | 261.30 Mn | 254.88 Mn | - | 2.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.25 Mn |
| Dec 31, 2025 | 23.45 Mn |
| Sep 30, 2025 | 1.37 Mn |
| Jun 30, 2025 | 1.24 Mn |
| Mar 31, 2025 | 1.41 Mn |
| Dec 31, 2024 | 1.02 Mn |
| Sep 30, 2024 | 2.13 Mn |
| Jun 30, 2024 | 3.46 Mn |
| Mar 31, 2024 | 4.47 Mn |
| Dec 31, 2023 | 6.27 Mn |
| Sep 30, 2023 | 5.75 Mn |
| Jun 30, 2023 | 5.14 Mn |
| Mar 31, 2023 | 5.12 Mn |
| Dec 31, 2022 | 6.60 Mn |
| Sep 30, 2022 | 5.08 Mn |
| Jun 30, 2022 | 3.59 Mn |
| Mar 31, 2022 | 7.33 Mn |
| Dec 31, 2021 | 4.74 Mn |
| Sep 30, 2021 | 3.04 Mn |
| Jun 30, 2021 | 3.62 Mn |